126 related articles for article (PubMed ID: 3298473)
1. Defective monocyte chemotaxis in active lepromatous leprosy.
Schuller-Levis G; Harris D; Cutler E; Meeker HC; Haubenstock H; Levis WR
Int J Lepr Other Mycobact Dis; 1987 Jun; 55(2):267-72. PubMed ID: 3298473
[TBL] [Abstract][Full Text] [Related]
2. IgM antibodies against phenolic glycolipid I from Mycobacterium leprae in leprosy sera: relationship to bacterial index and erythema nodosum leprosum.
Schwerer B; Meeker HC; Sersen G; Levis WR
Acta Leprol; 1984; 2(2-4):394-402. PubMed ID: 6398598
[TBL] [Abstract][Full Text] [Related]
3. Sequential monitoring of leprosy patients with serum antibody levels to phenolic glycolipid-I, a synthetic analog of phenolic glycolipid-I, and mycobacterial lipoarabinomannan.
Meeker HC; Schuller-Levis G; Fusco F; Giardina-Becket MA; Sersen E; Levis WR
Int J Lepr Other Mycobact Dis; 1990 Sep; 58(3):503-11. PubMed ID: 2205685
[TBL] [Abstract][Full Text] [Related]
4. Antibodies to phenolic glycolipid-I during long-term therapy: serial measurements in individual patients.
Miller RA; Gorder D; Harnisch JP
Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4):633-6. PubMed ID: 3323367
[TBL] [Abstract][Full Text] [Related]
5. IgM and IgG antibodies to phenolic glycolipid I from Mycobacterium leprae in leprosy: insight into patient monitoring, erythema nodosum leprosum, and bacillary persistence.
Levis WR; Meeker HC; Schuller-Levis G; Sersen E; Schwerer B
J Invest Dermatol; 1986 May; 86(5):529-34. PubMed ID: 3528312
[TBL] [Abstract][Full Text] [Related]
6. Antibody response to recombinant 65-kDa, 70-kDa and 18-kDa mycobacterial antigens in leprosy patients and healthy contacts in a leprosy-endemic population.
Ilangumaran S; Shankernarayan N; Ramu G; Muthukkaruppan V
Int J Lepr Other Mycobact Dis; 1994 Jun; 62(2):245-55. PubMed ID: 7519226
[TBL] [Abstract][Full Text] [Related]
7. Antibodies to phenolic glycolipid-1 and to whole Mycobacterium leprae in leprosy patients: evolution during therapy.
Bach MA; Wallach D; Flageul B; Hoffenbach A; Cottenot F
Int J Lepr Other Mycobact Dis; 1986 Jun; 54(2):256-67. PubMed ID: 3522769
[TBL] [Abstract][Full Text] [Related]
8. Serological activity of a characteristic phenolic glycolipid from Mycobacterium leprae in sera from patients with leprosy and tuberculosis.
Brett SJ; Draper P; Payne SN; Rees RJ
Clin Exp Immunol; 1983 May; 52(2):271-9. PubMed ID: 6407793
[TBL] [Abstract][Full Text] [Related]
9. Changes in circulating antibody levels to the major phenolic glycolipid during erythema nodosum leprosum in leprosy patients.
Andreoli A; Brett SJ; Draper P; Payne SN; Rook GA
Int J Lepr Other Mycobact Dis; 1985 Jun; 53(2):211-7. PubMed ID: 3894538
[TBL] [Abstract][Full Text] [Related]
10. ELISA detection of IgM antibodies against phenolic glycolipid-I in the management of leprosy: a comparison between laboratories.
Meeker HC; Levis WR; Sersen E; Schuller-Levis G; Brennan PJ; Buchanan TM
Int J Lepr Other Mycobact Dis; 1986 Dec; 54(4):530-9. PubMed ID: 3546543
[TBL] [Abstract][Full Text] [Related]
11. Serologic responses to Mycobacterium leprae-specific phenolic glycolipid-I antigen in sooty mangabey monkeys with experimental leprosy.
Gormus BJ; Ohashi DK; Ohkawa S; Walsh GP; Meyers WM; Brennan PJ; Trygg C
Int J Lepr Other Mycobact Dis; 1988 Dec; 56(4):537-45. PubMed ID: 2464657
[TBL] [Abstract][Full Text] [Related]
12. Serum IgA1 and IgM antibodies against Mycobacterium leprae-derived phenolic glycolipid-I: a comparative study in leprosy patients and their contacts.
Chujor CS; Bernheimer H; Levis WR; Schwerer B
Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):441-9. PubMed ID: 1890368
[TBL] [Abstract][Full Text] [Related]
13. Serodiagnosis of leprosy: relationships between antibodies to Mycobacterium leprae phenolic glycolipid I and protein antigens.
Levis WR; Meeker HC; Schuller-Levis GB; Gillis TP; Marino LJ; Zabriskie J
J Clin Microbiol; 1986 Dec; 24(6):917-21. PubMed ID: 3537003
[TBL] [Abstract][Full Text] [Related]
14. Quantitation of IgM antibodies to the M. leprae synthetic disaccharide can predict early bacterial multiplication in leprosy.
Hussain R; Jamil S; Kifayet A; Firdausi F; Dockrell HM; Lucas S; Hasan R
Int J Lepr Other Mycobact Dis; 1990 Sep; 58(3):491-502. PubMed ID: 2205684
[TBL] [Abstract][Full Text] [Related]
15. Detection of phenolic glycolipid-I antigen and antibody in sera from new and relapsed lepromatous patients treated with various drug regimens.
Cho SN; Cellona RV; Fajardo TT; Abalos RM; dela Cruz EC; Walsh GP; Kim JD; Brennan PJ
Int J Lepr Other Mycobact Dis; 1991 Mar; 59(1):25-31. PubMed ID: 2030314
[TBL] [Abstract][Full Text] [Related]
16. Antibodies to a synthetic analog of phenolic glycolipid-I of Mycobacterium leprae in healthy household contacts of patients with leprosy.
Menzel S; Harboe M; Bergsvik H; Brennan PJ
Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4):617-25. PubMed ID: 3323365
[TBL] [Abstract][Full Text] [Related]
17. Serum antibodies to defined carbohydrate antigens during the course of treated leprosy.
Gelber RH; Li F; Cho SN; Byrd S; Rajagopalan K; Brennan PJ
Int J Lepr Other Mycobact Dis; 1989 Dec; 57(4):744-51. PubMed ID: 2681457
[TBL] [Abstract][Full Text] [Related]
18. Early infection with M. leprae and antibodies to phenolic glycolipid-I in the nine-banded armadillo.
Job CK; Drain V; Truman RW; Sanchez RM; Hastings RC
Indian J Lepr; 1990; 62(2):193-201. PubMed ID: 2212734
[TBL] [Abstract][Full Text] [Related]
19. Humans respond predominantly with IgM immunoglobulin to the species-specific glycolipid of Mycobacterium leprae.
Young DB; Dissanayake S; Miller RA; Khanolkar SR; Buchanan TM
J Infect Dis; 1984 Jun; 149(6):870-3. PubMed ID: 6376654
[TBL] [Abstract][Full Text] [Related]
20. Assessment of anti-phenolic glycolipid-I IgM levels using an ELISA for detection of M. leprae infection in populations of the South Pacific Islands.
Cartel JL; Chanteau S; Boutin JP; Plichart R; Richez P; Roux JF; Grosset JH
Int J Lepr Other Mycobact Dis; 1990 Sep; 58(3):512-7. PubMed ID: 2205686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
